Literature DB >> 11805611

Editorial: recommendations regarding the use of methylprednisolone in acute spinal cord injury: making sense out of the controversy.

M G Fehlings.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11805611     DOI: 10.1097/00007632-200112151-00012

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


× No keyword cloud information.
  7 in total

1.  Methylprednisolone for acute spinal cord injury: not a standard of care.

Authors:  Herman Hugenholtz
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

Review 2.  Neuroprotection and acute spinal cord injury: a reappraisal.

Authors:  Edward D Hall; Joe E Springer
Journal:  NeuroRx       Date:  2004-01

Review 3.  Basic principles of management for cervical spine trauma.

Authors:  J K O'Dowd
Journal:  Eur Spine J       Date:  2009-08-22       Impact factor: 3.134

Review 4.  Antioxidant therapies in traumatic brain and spinal cord injury.

Authors:  Mona Bains; Edward D Hall
Journal:  Biochim Biophys Acta       Date:  2011-11-04

Review 5.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

6.  Methylprednisolone in acute spinal cord injuries.

Authors:  P A O'Connor; O McCormack; C Gavin; R Dungan; C Kirke; D McCormack; J O'Byrne; M Stephens; F McManus; M Walsh
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

Review 7.  Chemokines as possible targets in modulation of the secondary damage after acute spinal cord injury: a review.

Authors:  Peter Gál; Petra Kravcuková; Michal Mokrý; Darina Kluchová
Journal:  Cell Mol Neurobiol       Date:  2009-04-11       Impact factor: 5.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.